Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 11,413,000 | 11,156,000 | 10,571,000 | 9,741,000 | 9,189,000 |
| Cost of Goods | 3,029,000 | 2,857,000 | 2,717,000 | 2,665,000 | 2,656,000 |
| Gross Profit | 8,384,000 | 8,299,000 | 8,229,000 | 7,426,000 | 6,533,000 |
| Operating Expenses | 5,481,000 | 6,312,000 | 5,080,000 | 4,651,000 | 4,595,000 |
| Operating Income | 2,903,000 | 1,987,000 | 2,774,000 | 2,425,000 | 1,938,000 |
| Other Income | -332,000 | 0 | 10,000 | 8,000 | -661,000 |
| Pre-tax Income | 2,571,000 | 1,987,000 | 2,784,000 | 2,433,000 | 1,277,000 |
| Income Tax | 612,000 | 449,000 | 793,000 | 742,000 | 530,000 |
| Net Income Continuous | 2,269,128 | 2,107,853 | 2,055,505 | 1,747,703 | 746,775 |
| Net Income Discontinuous | 0 | 424,000 | 65,000 | 57,000 | 0 |
| Net Income | $1,959,000 | $1,962,000 | $2,056,000 | $1,748,000 | $747,000 |
| EPS Basic Total Ops | 0.95 | 0.95 | 0.99 | 0.83 | 0.54 |
| EPS Basic Continuous Ops | 1.11 | 1.02 | 0.99 | 0.83 | 0.36 |
| EPS Basic Discontinuous Ops | N/A | 0.20 | 0.03 | 0.03 | N/A |
| EPS Diluted Total Ops | 0.95 | 0.95 | 0.99 | 0.83 | 0.36 |
| EPS Diluted Continuous Ops | 1.11 | 1.02 | 0.99 | 0.83 | 0.36 |
| EPS Diluted Discontinuous Ops | N/A | 0.20 | 0.03 | 0.03 | N/A |
| EBITDA(a) | $3,211,000 | $2,282,000 | $3,020,000 | $2,669,000 | $2,134,000 |